Literature DB >> 31531100

Cell-bound Exopolysaccharide Extract from Indigenous Probiotic Bacteria Induce Apoptosis in HT-29 cell-line.

Parisa Mojibi1, Farzaneh Tafvizi2, Maryam Bikhof Torbati3.   

Abstract

BACKGROUND AND
OBJECTIVE: The aim of this study was to compare the cytotoxiceffects of local probiotic bacteria, including Lactobacillus paracasei, Lactobacillus brevis, while isolated from "Tarkhine" food and the induction of apoptosis in the HT-29 human colon adenocarcinoma cell line and normal fibroblasts.
METHODS: HT-29 and L-929 cell lines were treated with cell-bound exopolysaccharide extract (cb-EPS) from L. paracasei and L. brevis. The MTT assay was used to analyze cell viability. Cellular apoptosis was examined by flow cytometry and DNA fragmentation assay.
RESULTS: The cb-EPS from both probiotic bacteria prevented the proliferation of HT-29 colon cancer cells. In addi- tion, the cytotoxic and anti-proliferative effects of the exopolysaccharide extract from both bacteria in L-929 fibro- blasts were much lower than HT-29 cells. The induction of apoptosis in HT-29 cells was observed at 48h compared with 72h. It seems that the exopolysaccharides extracted from both bacteria have a greater effect on the induction of apoptosis at 48h. The cb-EPS of L. brevis showed more potent anti-proliferative and apoptotic properties than the cb- EPS of L. paracasei. The ladder pattern of DNA fragmentation confirmed the induction of apoptosis in cancer cells.
CONCLUSION: The results of the MTT assay and apoptosis indicate that the induction of apoptosis by the exopolysac- charide from bacteria depends on the dose, time, and strain of bacteria. Further studies may contribute toward the understanding of using these probiotic bacteria as biological products to treat and prevent cancers.

Entities:  

Keywords:  Apoptosis HT-29 Cells; Lactobacillus; Probiotic

Year:  2018        PMID: 31531100      PMCID: PMC6708565          DOI: 10.30699/IJP.14.1.41

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


  17 in total

Review 1.  Anti-carcinogenicity of probiotics and prebiotics.

Authors:  A J Burns; I R Rowland
Journal:  Curr Issues Intest Microbiol       Date:  2000-03

2.  Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells.

Authors:  Y Kim; S Oh; H S Yun; S Oh; S H Kim
Journal:  Lett Appl Microbiol       Date:  2010-04-29       Impact factor: 2.858

3.  Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro.

Authors:  S S Choi; Y Kim; K S Han; S You; S Oh; S H Kim
Journal:  Lett Appl Microbiol       Date:  2006-05       Impact factor: 2.858

4.  Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.

Authors:  Freddie Ann Hoffman; James T Heimbach; Mary Ellen Sanders; Patricia L Hibberd
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

Review 5.  Probiotic microbes: do they need to be alive to be beneficial?

Authors:  Jasmeet Kataria; Nan Li; James L Wynn; Josef Neu
Journal:  Nutr Rev       Date:  2009-09       Impact factor: 7.110

6.  Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria.

Authors:  Annaïg Lan; Dominique Lagadic-Gossmann; Christophe Lemaire; Catherine Brenner; Gwénaël Jan
Journal:  Apoptosis       Date:  2006-12-29       Impact factor: 4.677

7.  Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut.

Authors:  Alvaro Belenguer; Sylvia H Duncan; A Graham Calder; Grietje Holtrop; Petra Louis; Gerald E Lobley; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

8.  Contribution of acetate to butyrate formation by human faecal bacteria.

Authors:  Sylvia H Duncan; Grietje Holtrop; Gerald E Lobley; A Graham Calder; Colin S Stewart; Harry J Flint
Journal:  Br J Nutr       Date:  2004-06       Impact factor: 3.718

9.  Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp lactis in SNUC2A, a colon cancer cell line.

Authors:  Ji Yeon Kim; Hee Jong Woo; Young-Suk Kim; Kyoung Heon Kim; Hyong Joo Lee
Journal:  Nutr Cancer       Date:  2003       Impact factor: 2.900

10.  Isolation and characterization of two exopolysaccharides produced by Lactobacillus plantarum EP56.

Authors:  Richard Tallon; Philippe Bressollier; Maria C Urdaci
Journal:  Res Microbiol       Date:  2003-12       Impact factor: 3.992

View more
  4 in total

1.  Exploring the Therapeutic Potentials of Exopolysaccharides Derived From Lactic Acid Bacteria and Bifidobacteria: Antioxidant, Antitumor, and Periodontal Regeneration.

Authors:  Maha A Khalil; Fatma I Sonbol; Lamiaa A Al-Madboly; Tamer A Aboshady; Abeer S Alqurashi; Sameh S Ali
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

2.  Role of exopolysaccharides (EPSs) as anti-Mir-155 in cancer cells.

Authors:  Ahmed A Emam; Salwa M Abo-Elkhair; Mohamed Sobh; Ahmed M A El-Sokkary
Journal:  Heliyon       Date:  2021-04-08

Review 3.  An Update on the Effects of Probiotics on Gastrointestinal Cancers.

Authors:  Amirhossein Davoodvandi; Farzaneh Fallahi; Omid Reza Tamtaji; Vida Tajiknia; Zarrin Banikazemi; Hadis Fathizadeh; Mohammad Abbasi-Kolli; Michael Aschner; Maryam Ghandali; Amirhossein Sahebkar; Mohsen Taghizadeh; Hamed Mirzaei
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

4.  Inhibitory effects of probiotic Bacillus coagulans against MCF7 breast cancer cells.

Authors:  Masoumeh Dolati; Farzaneh Tafvizi; Masoud Salehipour; Tahereh Komeili Movahed; Parvaneh Jafari
Journal:  Iran J Microbiol       Date:  2021-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.